| abstract |
The invention concerns: (i) [4-(4-cyanobenzyl)phenyl]glycopyranosides of formula (I) wherein: the glycopyranosyl group R represents a beta -D arabinopyranosyl, beta -D-lyxopyranosyl, beta -D-ribopyranosyl, beta -D-mannopyranosyl, beta -L-arabinopyranosyl, beta -L-xylopyranosyl, alpha -L-arabinopyranosyl, alpha -L-xylopyranosyl or beta -L-rhamnopyranosyl group; and (ii) their esters resulting from esterification of at least a OH function of each glycopyranosyl group with a C2-C4 alkanoic or cycloalkanoic acid, as novel industrial products. Said novel [4-(4-cyanobenzyl)phenyl]glycopyranosides are useful in therapy for fighting against athermatous plaque. |